CIK 0001625297
- Large accelerated filer
Supernus, Inc.
Sign in to watch- Ticker
- SUPN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 412520873
- Phone
- +1 804-379-1090
- Business address
- 9715 KEY WEST AVENUE, ROCKVILLE, MD, 20850
- Former names
- Indivior Pharmaceuticals, Inc., INDIVIOR PLC
- 4 Shares withheld for taxes Chief Accounting Officer gave up 10,965 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 87,597 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 36,032 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 45,797 shares (to pay taxes)
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Grant or award Chief Accounting Officer acquired 6,903 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 37,358 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 26,897 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 33,622 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 31,380 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 79,976 shares (grant or award)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Grant or award Director acquired 3,722 shares (grant or award)
- 4 Grant or award Director acquired 5,955 shares (grant or award)
- 4 Grant or award Director acquired 3,722 shares (grant or award)
- 4 Grant or award Director acquired 3,722 shares (grant or award)
- 4 Grant or award Director acquired 3,722 shares (grant or award)
Page 5 of 29 · 572 filings